IMARC Group's report titled "Nucleic Acid Isolation and Purification Market Report by Product (Kits and Reagents, Instruments), Type (Plasmid DNA Isolation and Purification, Total RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, Genomic DNA Isolation and Purification, Messenger RNA Isolation and Purification, MicroRNA Isolation and Purification, PCR Cleanup, and Others), Method (Column-Based Isolation and Purification, Magnetic Bead-Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others), End User (Hospitals and Diagnostic Centers, Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Others), and Region 2024-2032". offers a comprehensive analysis of the industry, which comprises insights on the global nucleic acid isolation and purification market share. The global market size reached US$ 5.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/nucleic-acid-isolation-purification-market/requestsample

Factors Affecting the Growth of the Nucleic Acid Isolation and Purification Industry:     

• Advancements in Molecular Biology Techniques:  

The continuous evolution of molecular biology techniques has been a pivotal driver for the NAIP market. The development of more efficient, sensitive, and faster methods for isolating and purifying nucleic acids has significantly enhanced research capabilities across genomics, transcriptomics, and molecular diagnostics. These advancements facilitate the extraction of high-quality nucleic acids, which are crucial for accurate downstream applications, such as PCR, sequencing, and cloning. As molecular biology techniques become more sophisticated, the demand for advanced NAIP products that can deliver higher purity and yield increases, propelling the market growth.

• Increasing Prevalence of Genetic and Infectious Diseases:

The rising incidence of genetic and infectious diseases globally has increased the demand for NAIP technologies. Nucleic acid-based tests are essential for diagnosing these conditions, requiring efficient isolation and purification methods as a critical first step. The need for rapid, accurate, and high-throughput diagnostic solutions, especially in the face of outbreaks and pandemics, has led to significant investments in NAIP technologies. This driver emphasizes the critical role of NAIP in healthcare and its direct impact on improving patient outcomes and public health.    

• Growth in Personalized Medicine and Biomarker Discovery:

Personalized medicine and biomarker discovery rely heavily on the analysis of nucleic acids to understand genetic variations and their implications on disease and treatment. As personalized therapy approaches become more prevalent, the demand for NAIP technologies that can provide high-quality nucleic acids from various samples, including blood, tissue, and tumors increases. This growth is driving the need for more sophisticated isolation and purification solutions, capable of supporting the identification and validation of biomarkers for disease diagnosis, prognosis, and therapeutic interventions.

Leading Companies Operating in the Global Nucleic Acid Isolation and Purification Industry:

• Abcam plc
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Illumina Inc.
• Macherey-Nagel Gmbh & Co. Kg
• New England Biolabs
• Norgen Biotek Corp.
• Omega Bio-Tek Inc.
• Promega Corporation
• Qiagen
• Roche Molecular Systems Inc. (F. Hoffmann-La Roche AG)
• Takara Bio Inc. (Takara Holdings Inc.)
• Thermo Fisher Scientific Inc.

Nucleic Acid Isolation and Purification Market Report Segmentation:       

By Product:

• Kits and Reagents
• Instruments

Kits and reagents are the largest segment by product in the nucleic acid isolation and purification market due to their widespread use and convenience in laboratories.    

By Type:

• Plasmid DNA Isolation and Purification
• Total RNA Isolation and Purification
• Circulating Nucleic Acid Isolation and Purification
• Genomic DNA Isolation and Purification
• Messenger RNA Isolation and Purification
• microRNA Isolation and Purification
• PCR Cleanup
• Others

Plasmid DNA isolation and purification is the largest segment by type due to the significance of plasmid DNA in various research, diagnostics, and therapeutic applications.  

By Method:

• Column-Based Isolation and Purification
• Magnetic Bead-Based Isolation and Purification
• Reagent-Based Isolation and Purification
• Others

Column-based isolation and purification represent the largest segment by method due to their efficiency, reproducibility, and ease of use in nucleic acid purification workflows.     

By End User:

• Hospitals and Diagnostic Centers
• Academic and Government Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Others

Hospitals and diagnostic centers are the largest segment by end user as they require nucleic acid isolation and purification for a wide range of diagnostic tests and research purposes.   

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America emerges as the largest market by region due to the presence of well-established pharmaceutical and biotechnology industries, robust research infrastructure, and high adoption rates of advanced technologies in the region.

Nucleic Acid Isolation and Purification Market Trends:

The integration of automation and technological innovations in NAIP protocols has transformed the landscape of nucleic acid extraction and purification. Automated systems offer high throughput, reproducibility, and reduced contamination risk, meeting the needs of both research and clinical diagnostics. This automation, coupled with innovations in reagents and kits that enable faster and more efficient isolation processes, addresses the growing demand for scalable and reliable NAIP solutions. The push towards automation and innovation reflects the market's response to the need for higher productivity and efficiency in nucleic acid-based analyses.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163